BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: dos Santos Fernandes CJ, Jardim CV, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R. Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol. 2010;56:715-720. [PMID: 20723801 DOI: 10.1016/j.jacc.2010.03.065] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Alves JL, Gavilanes F, Jardim C, Fernandes CJCDS, Morinaga LTK, Dias B, Hoette S, Humbert M, Souza R. Pulmonary Arterial Hypertension in the Southern Hemisphere. Chest 2015;147:495-501. [DOI: 10.1378/chest.14-1036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
2 Butrous G. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Schistosomiasis and pulmonary arterial hypertension. Ann Thorac Med 2014;9:S38-41. [PMID: 25076995 DOI: 10.4103/1817-1737.134019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 . Current world literature. Curr Opin Cardiol 2011;26:356-61. [PMID: 21654380 DOI: 10.1097/HCO.0b013e328348da50] [Reference Citation Analysis]
4 Seferian A, Simonneau G. [Pulmonary hypertension: definition, diagnostic and new classification]. Presse Med 2014;43:935-44. [PMID: 25127985 DOI: 10.1016/j.lpm.2014.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Fonseca AXC, Valois FM, Ferreira EVM, Oliveira RKF, Ramos RP, Messina CMS, Costa CMO, Nery LE, Ota-arakaki J. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival. Liver Transpl 2016;22:562-3. [DOI: 10.1002/lt.24390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Papamatheakis DG, Mocumbi AO, Kim NH, Mandel J. Schistosomiasis-associated pulmonary hypertension. Pulm Circ 2014;4:596-611. [PMID: 25610596 DOI: 10.1086/678507] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
7 Lapa M, Acencio MM, Farias AQ, Teixeira LR, Fernandes CJ, Jardim CP, Terra-Filho M. Selectins and platelet-derived growth factor (PDGF) in schistosomiasis-associated pulmonary hypertension. Lung 2014;192:981-6. [PMID: 25218335 DOI: 10.1007/s00408-014-9643-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
8 McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of pulmonary arterial hypertension. J Am Coll Cardiol 2015;65:1976-97. [PMID: 25953750 DOI: 10.1016/j.jacc.2015.03.540] [Cited by in Crossref: 214] [Cited by in F6Publishing: 172] [Article Influence: 30.6] [Reference Citation Analysis]
9 Vorselaars VM, Velthuis S, Snijder RJ, Vos JA, Mager JJ, Post MC. Pulmonary hypertension in hereditary haemorrhagic telangiectasia. World J Cardiol 2015; 7(5): 230-237 [PMID: 26015855 DOI: 10.4330/wjc.v7.i5.230] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
10 Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Mechanisms of disease: pulmonary arterial hypertension. Nat Rev Cardiol 2011;8:443-55. [PMID: 21691314 DOI: 10.1038/nrcardio.2011.87] [Cited by in Crossref: 415] [Cited by in F6Publishing: 385] [Article Influence: 37.7] [Reference Citation Analysis]
11 McGlothlin D. Classification of pulmonary hypertension. Heart Fail Clin 2012;8:301-17. [PMID: 22748896 DOI: 10.1016/j.hfc.2012.04.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Rigaud P, Traclet J, Cottin V. [Etiological diagnosis of pulmonary hypertension: A cause of difficult diagnosis]. Rev Mal Respir 2019;36:350-4. [PMID: 30473449 DOI: 10.1016/j.rmr.2018.11.004] [Reference Citation Analysis]
13 Botoni FA, Marinho CC, Carvalho VT, Mickael CS, Graham BB. A retrospective study of schistosomiasis-associated pulmonary hypertension from an endemic area in Brazil. Int J Cardiol Heart Vasc 2019;24:100387. [PMID: 31334331 DOI: 10.1016/j.ijcha.2019.100387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Valois FM, Nery LE, Ramos RP, Ferreira EV, Silva CC, Neder JA, Ota-Arakaki JS. Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment. PLoS One 2014;9:e87699. [PMID: 24498356 DOI: 10.1371/journal.pone.0087699] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
15 Fernandes CJC, Jardim C, Souza R. The global view. Curr Opin Pulm Med 2019;25:391-7. [PMID: 31365371 DOI: 10.1097/MCP.0000000000000603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Dorfmüller P, Humbert M. Progress in Pulmonary Arterial Hypertension Pathology: Relighting a Torch Inside the Tunnel. Am J Respir Crit Care Med 2012;186:210-2. [DOI: 10.1164/rccm.201206-1049ed] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kherbeck N, Tamby MC, Bussone G, Dib H, Perros F, Humbert M, Mouthon L. The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin Rev Allergy Immunol 2013;44:31-8. [PMID: 21394427 DOI: 10.1007/s12016-011-8265-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
18 Greenwood JC, Spangler RM. Management of Crashing Patients with Pulmonary Hypertension. Emerg Med Clin North Am 2015;33:623-43. [PMID: 26226870 DOI: 10.1016/j.emc.2015.04.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Graham BB, Kumar R. Schistosomiasis and the pulmonary vasculature (2013 Grover Conference series). Pulm Circ 2014;4:353-62. [PMID: 25621148 DOI: 10.1086/675983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 Knafl D, Gerges C, King CH, Humbert M, Bustinduy AL. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review. Eur Respir Rev 2020;29:190089. [DOI: 10.1183/16000617.0089-2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Piscoya Roncal CG, Mendes AA, Muniz MTC, de Oliveira SA, do Valle Neto LM, de Vasconcellos Piscoya NA, Góes GHB, Sobral Filho DC, Gomberg-Maitland M. Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil. Int J Cardiol Heart Vasc 2019;25:100373. [PMID: 31720370 DOI: 10.1016/j.ijcha.2019.100373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Campos C, de Castro AL, Tavares AM, Fernandes RO, Ortiz VD, Barboza TE, Pereira C, Apel M, da Silva OS, Llesuy S, Araujo AS, Belló-Klein A. Effect of Free and Nanoencapsulated Copaiba Oil on Monocrotaline-induced Pulmonary Arterial Hypertension. J Cardiovasc Pharmacol 2017;69:79-85. [PMID: 27798416 DOI: 10.1097/FJC.0000000000000442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
23 Kolosionek E, King J, Rollinson D, Schermuly RT, Grimminger F, Graham BB, Morrell N, Butrous G. Schistosomiasis causes remodeling of pulmonary vessels in the lung in a heterogeneous localized manner: Detailed study. Pulm Circ 2013;3:356-62. [PMID: 24015336 DOI: 10.4103/2045-8932.114764] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
24 Posada-martínez EL, Gonzalez-barrera LG, Liblik K, Gomez-mesa JE, Saldarriaga C, Farina JM, Parodi J, Zhou Z, Martinez-selles M, Baranchuk A. Esquistossomose e o Coração - Em Nome das Doenças Tropicais Negligenciadas e Outras Doenças Infecciosas que Afetam o Coração (Projeto NET-Heart). Arquivos Brasileiros de Cardiologia 2021. [DOI: 10.36660/abc.20201384] [Reference Citation Analysis]
25 Ota-Arakaki JS, Campos FTAF, Souza R. World Pulmonary Hypertension Day: reflections and planning. J Bras Pneumol 2021;47:e20210251. [PMID: 34287559 DOI: 10.36416/1806-3756/e20210251] [Reference Citation Analysis]
26 Fernandes CJCDS, Jardim CVP, Hovnanian A, Hoette S, Morinaga LK, Souza R. Schistosomiasis and pulmonary hypertension. Expert Review of Respiratory Medicine 2014;5:675-81. [DOI: 10.1586/ers.11.58] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
27 Jiang X, Jing ZC. Epidemiology of pulmonary arterial hypertension. Curr Hypertens Rep 2013;15:638-49. [PMID: 24114080 DOI: 10.1007/s11906-013-0397-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
28 Fernandes CJC, Piloto B, Castro M, Gavilanes Oleas F, Alves JL Jr, Lopes Prada LF, Jardim C, Souza R. Survival of patients with schistosomiasis-associated pulmonary arterial hypertension in the modern management era. Eur Respir J 2018;51:1800307. [PMID: 29622571 DOI: 10.1183/13993003.00307-2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
29 Breda AP, Pereira de Albuquerque AL, Jardim C, Morinaga LK, Suesada MM, Fernandes CJ, Dias B, Lourenço RB, Salge JM, Souza R. Skeletal muscle abnormalities in pulmonary arterial hypertension. PLoS One 2014;9:e114101. [PMID: 25460348 DOI: 10.1371/journal.pone.0114101] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
30 Fernandes CJ, Dias BA, Jardim CV, Hovnanian A, Hoette S, Morinaga LK, Souza S, Suesada M, Breda AP, Souza R. The Role of Target Therapies in Schistosomiasis-Associated Pulmonary Arterial Hypertension. Chest 2012;141:923-8. [DOI: 10.1378/chest.11-0483] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
31 Fernandes CJ, Martins BC, Jardim CV, Ciconelli RM, Morinaga LK, Breda AP, Hoette S, Souza R. Quality of life as a prognostic marker in pulmonary arterial hypertension. Health Qual Life Outcomes 2014;12:130. [PMID: 25176512 DOI: 10.1186/s12955-014-0130-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
32 Gavilanes F, Fernandes CJ, Souza R. Pulmonary arterial hypertension in schistosomiasis. Current Opinion in Pulmonary Medicine 2016;22:408-14. [DOI: 10.1097/mcp.0000000000000300] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
33 van der Feen DE, Bartelds B, de Boer RA, Berger RMF. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. Eur Heart J 2017;38:2034-41. [PMID: 28369399 DOI: 10.1093/eurheartj/ehx034] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 9.8] [Reference Citation Analysis]
34 Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-hahnle K, Jing Z, Gibbs JSR. A global view of pulmonary hypertension. The Lancet Respiratory Medicine 2016;4:306-22. [DOI: 10.1016/s2213-2600(15)00543-3] [Cited by in Crossref: 189] [Cited by in F6Publishing: 93] [Article Influence: 31.5] [Reference Citation Analysis]
35 Ferrari TCA, Albricker ACL, Gonçalves IM, Freire CMV. Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis. Front Cardiovasc Med 2021;8:724254. [PMID: 34676250 DOI: 10.3389/fcvm.2021.724254] [Reference Citation Analysis]
36 Gidwani S, Nair A. The burden of pulmonary hypertension in resource-limited settings. Glob Heart 2014;9:297-310. [PMID: 25667181 DOI: 10.1016/j.gheart.2014.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
37 Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology 2013;62:D34-41. [DOI: 10.1016/j.jacc.2013.10.029] [Cited by in Crossref: 1761] [Cited by in F6Publishing: 1454] [Article Influence: 195.7] [Reference Citation Analysis]
38 Sibomana JP, Campeche A, Carvalho-Filho RJ, Correa RA, Duani H, Pacheco Guimaraes V, Hilton JF, Kassa B, Kumar R, Lee MH, Loureiro CMC, Mazimba S, Mickael C, Oliveira RKF, Ota-Arakaki JS, Rezende CF, Silva LCS, Sinkala E, Ahmed HY, Graham BB. Schistosomiasis Pulmonary Arterial Hypertension. Front Immunol 2020;11:608883. [PMID: 33362796 DOI: 10.3389/fimmu.2020.608883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hoette S, Figueiredo C, Dias B, Alves JL Jr, Gavilanes F, Prada LF, Jasinowodolinski D, Morinaga LT, Jardim C, Fernandes CJ, Souza R. Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension. BMC Pulm Med 2015;15:118. [PMID: 26459359 DOI: 10.1186/s12890-015-0115-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
40 Butrous G. Schistosome infection and its effect on pulmonary circulation. Glob Cardiol Sci Pract 2019;2019:5. [PMID: 31024947 DOI: 10.21542/gcsp.2019.5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
41 Polonio IB, Acencio MMP, Pazetti R, Almeida FMD, Canzian M, Silva BSD, Pereira KAB, Souza RD. Comparação de dois modelos experimentais de hipertensão pulmonar. J bras pneumol 2012;38:452-60. [DOI: 10.1590/s1806-37132012000400007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]